Neurogenetic Thematic Research Group Expands Collaboration with National Cerebral and Cardiovascular Research Center (NCVC), Osaka, Japan

The Neurogenetic Thematic Research Group (NTRG) has significantly expanded its collaborative efforts by deepening its partnership with the Department of Neurology at the renowned National Cerebral and Cardiovascular Research Center (NCVC) in Osaka, Japan. This collaboration highlights the growing academic and research ties between Hasanuddin University (Unhas) in Indonesia and Japan’s leading neuroscience institutions.

The meeting, held at NCVC on 29 July 2025, featured an insightful presentation by Dr. Shuichi Tonomura, who provided an update on the ongoing field research conducted at Hasanuddin University. His report outlined key findings and highlighted the progress made in various research projects. Dr. Tonomura also shared an update on the human microbiome research protocol, which has received approval from the NCVC ethics committee. This research, exploring the links between the human microbiome and neurovascular diseases, holds great promise for advancing cerebrovascular research.

In addition to these updates, Dr. Tonomura presented future collaborative projects, including the highly anticipated Yusran Ady Fitrah Project. Key research initiatives discussed include the NOTCH3 gene study, which investigates the genetic basis of cerebral small vessel disease (CSVD), and the RNF213 research project, which explores genetic factors related to cerebrovascular diseases.

The event was attended by prominent figures from both institutions, including Prof. Dr. Masafumi Ihara, Dr. Tomotaka Tanaka, and Dr. Satoshi Saito from NCVC, along with distinguished members of Hasanuddin University’s Department of Neurology. These included Prof. Muhammad Akbar, SpN(K), PhD, and Dr. Cahyono Kaelan, PhD, SpN(K), SpPA(K). Other key attendees from Unhas included Dr. Faisal Budisasmita Parawansa Akbar, SpN, and Dr. Gita Vita Soraya, PhD, SpN.

This strengthened partnership between Hasanuddin University and NCVC represents a significant milestone in the global advancement of neurogenetics, particularly in cerebrovascular research. The collaboration is set to provide invaluable insights into the genetic factors influencing these diseases, paving the way for new diagnostic and therapeutic strategies that can impact both nations and beyond.